HLA003
A549 HLA Panel Cell Lines
human lung (Carcinoma), Epithelial
About This Item
Recommended Products
product name
A549 HLA Panel Cell Lines,
biological source
human lung (Carcinoma)
growth mode
Adherent
morphology
Epithelial
shipped in
dry ice
storage temp.
−196°C
General description
This product is a panel of eleven (11) genetically modified cell lines targeting MHC Class I HLA molecules in an A549 lung carcinoma parental cell line background. The full HLA panel consists of a Beta-2 microglobulin (β2M) knockout cell line and an additional ten (10) monoallelic HLA expression cell lines.
CompoZr® Zinc Finger Nuclease (ZFN) technology was used to generate the β2M knockout cell line, which does not express endogenous cell surface MHC Class I HLA molecules (HLA-A or HLA-B) as measured by fluorescence-activated cell sorting (FACS).
MISSION® lentivirus was used to generate the ten (10) monoallelic HLA cell lines, which express individual HLA-A or HLA-B subtypes on the cell surface via a β2M:HLA fusion protein as described in Nature Biotechnology 35, 765-772, (2017) and as demonstrated via FACS analysis.
Cell Line Description
Features and Benefits
Components
HLA003B-1VL: A549 HLA-A*02:01 Cells
HLA003C-1VL: A549 HLA-A*01:01 Cells
HLA003D-1VL: A549 HLA-A*03:01 Cells
HLA003E-1VL: A549 HLA-A*11:01 Cells
HLA003F-1VL: A549 HLA-A*24:02 Cells
HLA003G-1VL: A549 HLA-B*15:10 Cells
HLA003H-1VL: A549 HLA-B*07:02 Cells
HLA003I-1VL: A549 HLA-B*08:01 Cells
HLA003J-1VL: A549 HLA-B*35:01 Cells
HLA003K-1VL: A549 HLA-B*40:01 Cells
Quality
Legal Information
Disclaimer
Storage Class
10 - Combustible liquids
Choose from one of the most recent versions:
Certificates of Analysis (COA)
Sorry, we don't have COAs for this product available online at this time.
If you need assistance, please contact Customer Support.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Articles
Whether you need screening tools for CAR/TCR therapies and mAB development, target cells for efficacy testing, or potency assays for clinical development, we provide functional biologically-relevant solutions to help you save time, accelerate your immuno-oncology research, and simplify your workflow.
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service